IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BML Capital Management, LLC

Q4 2022 Holdings

Filed 2023-02-13 | 25 holdings | $104.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Abercrombie & Fitch Co(ANF)CL A002896207$13.1M571,11712.5%
Imara IncCOM45249V107$12.3M3,017,77411.8%
Tillys Inc(TLYS)CL A886885102$10.5M1,154,84410.0%
Disc Medicine Inc(IRON)COM254604101$9.9M500,0009.5%
Spdr SER TR(BIL)BLOOMBERG 1-3 MO78468R663$9.1M100,0008.7%
Pardes Biosciences IncCOM69945Q105$8.2M4,867,9847.9%
Eliem Therapeutics Inc(CLYM)COM28658R106$6.7M1,825,1346.4%
Satsuma Pharmaceuticals IncCOM80405P107$5.8M6,440,0005.5%
Sesen BIO IncCOM817763105$5.0M8,227,9694.8%
Adverum Biotechnologies Inc(ADVMCHF)COM00773U108$4.1M7,067,1793.9%
Verrica Pharmaceuticals IncCOM92511W108$3.1M1,110,6052.9%
Metacrine IncCOM59101E103$2.8M6,167,4582.6%
Athira Pharma IncCOM04746L104$2.3M714,7632.2%
Astrotech Corp(ASTC)COM046484309$2.2M220,4102.1%
Arca Biopharma Inc(ABIOEUR)COM00211Y506$2.0M858,2561.9%
Richardson Electrs LTD(RELL)COM763165107$2.0M95,3591.9%
Forte Biosciences Inc(TOCAEUR)COM34962G109$1.5M1,461,3641.4%
Retractable Technologies Inc(RVP)COM76129W105$1.1M668,5751.0%
Milestone Pharmaceuticals in(MIST)COM59935V107$712.8K180,0000.7%
Graybug Vision IncCOMMON38942Q103$618.0K1,235,9430.6%
Lisata Therapeutics Inc(LSTA)COM128058302$616.9K243,8390.6%
Passage BIO IncCOM702712100$465.7K337,4670.4%
Adicet BIO Inc(TORCEUR)COM007002108$268.2K30,0000.3%
Spruce Biosciences IncCOM85209E109$243.4K221,8300.2%
Elevation Oncology IncCOM28623U101$38.0K39,9630.0%